BioRestorative Therapies Receives A Second Patent in Australia For Its Metabolic Program
October 23, 2019 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Oct. 23, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that the...
BioRestorative Therapies Scientific Advisory Board Member and Clinical Director of Regenerative Disc/Spine Program, Dr. Wayne J. Olan, to Receive Prestigious Award
September 16, 2019 08:00 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Sept. 16, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that a...
BioRestorative Therapies Comments on Recent Promotional Activity
September 13, 2019 20:00 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Sept. 13, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell - based therapies, is providing comment on...
BioRestorative Therapies Announces New Initiative to Target Polycystic Ovarian Syndrome
September 11, 2019 08:00 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Sept. 11, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
BioRestorative Therapies’ Stockholders Approve Institutional Investor Agreement and Exchange Agreements
September 05, 2019 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Sept. 05, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that, at...
BioRestorative Therapies Signs $5.4 Million Financing with Institutional Investor
July 31, 2019 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., July 31, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today announced that it...
BioRestorative Therapies to Present at the 22nd Annual American Society of Gene and Cell Therapy as to Data on its Platform Technology for the Treatment of Metabolic Disorders
April 29, 2019 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., April 29, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Announces the Creation of a Disc Advisory Committee
February 27, 2019 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Feb. 27, 2019 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in the United States
November 15, 2018 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Nov. 15, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today...
BioRestorative Therapies Announces the Appointment of Lance Alstodt as Executive VP and Chief Strategy Officer
October 18, 2018 09:45 ET
|
BioRestorative Therapies, Inc.
MELVILLE, N.Y., Oct. 18, 2018 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative" or the “Company") (OTC:BRTX), a life sciences company focused on stem cell-based therapies, today...